Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

Go back to Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress
(NASDAQ: AUTL) Delayed: 1.51 -0.02 (1.31%)
Previous Close $1.53    52 Week High
Open $1.55    52 Week Low
Day High $1.59    P/E N/A 
Day Low $1.51    EPS
Volume 844,822